Presently, 19 different GLP-1 analogues are in development for the treatment of obesity by almost as many companies
The FDA recommends using a non-oral contraceptive method or adding a barrier method for 4 weeks after starting treatment and for 4 weeks after each dose increase
Across the trials, the time-to-event model estimated that the time to no difference between the intervention and controls was 1.4 years, 1.1 years and 1.3 years, respectively, after cessation of the three groups of drugs
doi:10.1038/s41392-024-01951-9 Uusitupa M, Khan TA, Viguiliouk E, et al
In weight loss trials, individuals administered semaglutide experienced significant reductions in body weight and BMI compared to those who received a placebo
The medication's effects on digestion mean gas episodes can occur without warning, often in higher volumes than typical digestive upset, and with unpredictable timing that makes strategic planning nearly impossible
